Bajaj Healthcare Limited (BHL) on Wednesday announced that it has received license from DRDO to manufacture 2-DG drug used in control and treatment of Covid-19. Established in 1993, Bajaj Healthcare Limited specialises in manufacturing of Amino Acids, Intermediates, API, formulations & Nutraceuticals. The government has recently launched 2-DG as an anti -Covid-19 therapeutic application of the drug 2-Deoxy-D-glucose. Patients treated with 2-DG have shown negative RT-PCR in COVID-19 patients. The 2-DG drug comes in powder form in the sachet, which is taken orally by dissolving it in water.

Source: Mint July 07, 2021 13:17 UTC